Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human Epidermal Growth Factor Receptor 1 (EGFR/HER1) is a transmembrane receptor tyrosine kinase that plays a critical role in cell growth, proliferation, differentiation, and survival. Upon ligand binding, EGFR undergoes dimerization and autophosphorylation, leading to the activation of downstream signaling pathways such as RAS-RAF-MEK-ERK and PI3K-AKT. Aberrant EGFR signaling is frequently observed in various cancers, making it a key therapeutic target. Therapeutic strategies include monoclonal antibodies and small molecule inhibitors that block ligand binding or tyrosine kinase activity.
Inhibition of tyrosine kinase activity or ligand binding, leading to reduced downstream signaling.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Epidermal Growth Factor Receptor 1 (EGFR/HER1).